Financials data is unavailable for this security.
View more
Year on year Asia Medical & Agricultural Laboratory & Research Center PCL had net income fall -33.56% from 14.52m to 9.64m despite a 9.88% increase in revenues from 263.22m to 289.21m. An increase in the cost of goods sold as a percentage of sales from 25.07% to 62.49% was a component in the falling net income despite rising revenues.
| Gross margin | 23.60% |
|---|---|
| Net profit margin | 6.42% |
| Operating margin | 8.27% |
| Return on assets | 3.13% |
|---|---|
| Return on equity | 3.93% |
| Return on investment | 3.46% |
More ▼
Cash flow in THBView more
In 2023, cash reserves at Asia Medical & Agricultural Laboratory & Research Center PCL fell by 14.39m. However, the company earned 45.36m from its operations for a Cash Flow Margin of 15.68%. In addition the company generated 22.44m cash from investing, though they paid out 82.20m more in financing than they received.
| Cash flow per share | 0.1413 |
|---|---|
| Price/Cash flow per share | 10.05 |
| Book value per share | 1.22 |
|---|---|
| Tangible book value per share | 1.17 |
More ▼
Balance sheet in THBView more
| Current ratio | 3.25 |
|---|---|
| Quick ratio | 3.08 |
| Total debt/total equity | 0.102 |
|---|---|
| Total debt/total capital | 0.0926 |
More ▼
Growth rates in THB
Year on year, growth in earnings per share excluding extraordinary items dropped -33.56%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.57% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 123.48% |
| EPS growth(5 years) | -5.84 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 261.70 |
More ▼
